Screening Protocol

Inclusion Criteria: * Subjects 22 years of age or older on the date of data collection (retrospective) or informed consent (prospective). * For prospective data collection or missing retrospective data collection, subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent. * BCVA 20/40 or better (each eye). * Normal eyes to have normal ocular examination in both eyes * Normal eyes to have IOP ≤ 21 mmHg in both eyes * Pathology eyes to have clinical diagnosis of mild or moderate glaucoma in at least one eye Exclusion Criteria: * For prospective or missing retrospective data collection, subjects unable to tolerate ophthalmic testing. * Concomitant diseases known to affect the visual field: history of leukemia, dementia, Parkinson's disease, Alzheimer's disease, stroke, or autoimmune diseases. * History of intraocular surgery (uncomplicated cataract or glaucoma surgeries are accepted) * Ocular findings or history of co-morbidities, including, but not limited to: uveitis, non-glaucomatous optic neuropathy, trauma, retinal detachment, vein or artery occlusions, wet age-related macular degeneration, geographic atrophy, proliferative diabetic retinopathy, vitreous hemorrhage, severe cataract, severe non-proliferative diabetic retinopathy. Controlled diabetes and hypertension participants can be included. * Unreliable VF testing and/or poor-quality OCT scans. * Poor fixation. * Pathology eyes with severe glaucoma * Pathology eyes with glaucoma suspect diagnosis * Pathology eyes with Ocular Hypertensive diagnosis